Everyday investors could have lost 30% or more during the coronavirus crash depending on how they've invested. It can be hard to look at the numbers....
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
(Bloomberg) -- An experimental coronavirus vaccine could be available to health-care workers as soon as this fall on an emergency basis. U.S. President Donald Trump began talking privately late last week about reopening the nation to curb the economic rout.Finance ministers and central bank governors from the Group of 20 nations joined an emergency call on Monday to discuss their response to the pandemic.The Federal Reserve announced a second wave of initiatives to support the U.S. economy, boosting stocks after Democrats blocked the Senate from advancing a rescue plan. Germany approved an $800 billion package, with Chancellor Angela Merkel in quarantine.Japanese Prime Minister Shinzo Abe said a postponement of the Olympics may be inevitable and the crisis engulfing the aviation industry deepened.Key Developments:Cases top 350,000 and 15,308 dead: Johns Hopkins tallyEurope struggles to get ahead of virus with toll mountingFed’s Bullard says U.S. unemployment may hit 30% in 2QRecession guaranteed, recovery...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
John Inch, Gordon Haskett Senior Analyst, joins Yahoo Finance’s Alexis Christoforous and Brian Sozzi to discuss General Electric and how it's naviagting through the coronavirus outbreak....
Shares of Aytu Bioscience Inc (NASDAQ: AYTU), which announced earlier this month a deal to distribute a COVID-19 test, were rallying Monday after the company announced FDA approval for distribution of the test. The Engelwood, Colorado-based specialty pharma company said it has received confirmation from the FDA that it may begin distribution of its COVID-19 IgG/IgM Rapid Test throughout the U.S.The test, according to Aytu, is intended for professional use and delivers results in 2-10 minutes at the point-of-care.It is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the new coronavirus in human whole blood, serum or plasma."This point-of-care test has been validated in a 126-patient clinical trial and is CE marked," according to Aytu. Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Aytu said it expects...
(Bloomberg) -- U.S. President Donald Trump began talking privately late last week about reopening the nation to curb the economic rout. Earlier on Monday, he said measures shouldn’t be “worse than the problem itself” and later retweeted posts calling for healthy people to return to work after 15 days of precautions.Finance ministers and central bank governors from the Group of 20 nations joined an emergency call on Monday to discuss their response to the pandemic.The Federal Reserve announced a second wave of initiatives to support the U.S. economy, boosting stocks after Democrats blocked the Senate from advancing a rescue plan. Germany approved an $800 billion package, with Chancellor Angela Merkel in quarantine.Japanese Prime Minister Shinzo Abe said a postponement of the Olympics may be inevitable and the crisis engulfing the aviation industry deepened.Key Developments:Cases at 349,211 and 15,308 dead: Johns Hopkins tallyEurope struggles to get ahead of virus with toll mountingFed’s...